Cell Matters logo — Enhancing cell therapy productivity with advanced cryopreser...

Cell Matters

Enhancing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant services.

Founded 2017 Series A Total: $1.01M Biotechnology, Health and Wellness

General Information

Company Name Cell Matters
Founded Year 2017
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Cell Matters. To contact Cell Matters, visit vitricell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cell Matters compare?

A PDF of Cell Matters and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cell Matters soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cell Matters

Cell Matters, founded in 2017, is revolutionizing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant services. The company's slogan, "Enhancing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant services," encapsulates its core mission. By offering an integrated set of GMP services, Cell Matters is ensuring its alignment with the regulatory, quality, and GMP requirements of the cell therapy industry within the biotechnology sector. In January 2018, the company secured a significant €712.00K Series A investment, with key investors including Gesval, Spinventure, and Jean-Pierre Delwart. This capital injection signifies a strong investor confidence in Cell Matters' innovative approach and its potential to make a lasting impact in the field of biotechnology.

Business keywords: cell therapy, cryopreservation, GMP services, regulatory compliance, quality standards, cell preservation, cellular therapy, biopharmaceuticals

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €712.00K 3
Gesval, Spinventure +1
23 Jan 2018
Grant €300.00K 2
Walloon, WBC incubator
23 Jan 2018

Cell Matters Alternatives & Competitors

View All Alternatives
Cell Matters vs
VintaBio
VintaBio United States

VintaBio delivers customized process development and GMP manufacturing service for cell and gene the...

Venture round
31 employees
Biotechnology, Health and Wellness
Cell Matters vs
ProtaGene
ProtaGene Germany

Analytic services for biologics and cell therapies

Growth
130 employees
Biopharma, Biotechnology
Cell Matters vs
Evia Bio
Evia Bio United States

Better and Safer Therapeutics Enabled by All-Natural Cryopreservation.

Private Equity
11 employees
Biotechnology, Health and Wellness

FAQ About Cell Matters

Enhancing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant services.
Cell Matters was founded in 2017.
Cell Matters operates in Biotechnology and Health and Wellness. Its work centres on cell therapy, cryopreservation, GMP services and regulatory compliance.
Cell Matters has completed 2 funding rounds, raising a total of $1.01M. The latest funding stage is Series A.
Top alternatives and competitors to Cell Matters include VintaBio, ProtaGene, Evia Bio, Stelis Biopharma, Rebirthel Co.,Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cell Matters and VintaBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cell Matters, https://bouncewatch.com/company/cell-matters, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes